Literature DB >> 30948247

The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease.

Aline Almeida Gulart1, Anelise Bauer Munari1, Suelen Roberta Klein1, Raysa Silva Venâncio2, Hellen Fontão Alexandre2, Anamaria Fleig Mayer3.   

Abstract

OBJECTIVE: To determine the cut-off point for the London Chest Activity of Daily Living scale in order to better discriminate functional status. Secondarily, to determine which of the scores (total or %total) is better associated with clinical outcomes of a pulmonary rehabilitation program.
METHODS: Sixty-one patients with chronic obstructive pulmonary disease performed the following tests: spirometry; Chronic Obstructive Pulmonary Disease Assessment Test; Saint George's Respiratory Questionnaire; modified Medical Research Council, the body-mass index, airflow obstruction, dyspnea, and exercise capacity index; six-minute walk test; physical activity in daily life assessment and London Chest Activity of Daily Living scale. Thirty-eight patients were evaluated pre- and post-pulmonary rehabilitation . The cut-off point was determined using the receiver operating characteristic curve with six-minute walk test (cut-off point: 82%pred), modified Medical Research Council (cut-off point: 2), level of physical (in)activity (cut-off point: 80min per day in physical activity ≥3 metabolic equivalent of task) and presence/absence of severe physical inactivity (cut-off point: 4580 steps per day) as anchors.
RESULTS: A cut-off point found for all anchors was 28%: modified Medical Research Council [sensitivity=83%; specificity=72%; area under the curve=0.80]; level of physical (in)activity [sensitivity=65%; specificity=59%; area under the curve=0.67] and classification of severe physical inactivity [sensitivity=70%; specificity=62%; area under the curve=0.70]. The patients who scored ≤28% in %total score of London Chest Activity of Daily Living had lower modified Medical Research Council , Chronic Obstructive Pulmonary Disease Assessment Test, Saint George's Respiratory Questionnaire, body-mass index, airflow obstruction, dyspnea and exercise capacity index and sitting time than who scored >28%, and higher forced expiratory volume in the first second, time in physical activity ≥3 metabolic equivalent of task, steps per day and six-minute walk distance. The %total score of London Chest Activity of Daily Living correlated better with clinical outcomes than the total score.
CONCLUSIONS: The cut-off point of 28% is sensitive and specific to distinguish the functional status in patients with chronic obstructive pulmonary disease. The %total score of the London Chest Activity of Daily Living reflects better outcomes of chronic obstructive pulmonary disease when compared to total score.
Copyright © 2019 Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia. Publicado por Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Activities of daily living; Chronic obstructive pulmonary disease; Exercise; Interpretability; Outcome assessment (health care).; Rehabilitation

Year:  2019        PMID: 30948247      PMCID: PMC7253922          DOI: 10.1016/j.bjpt.2019.03.002

Source DB:  PubMed          Journal:  Braz J Phys Ther        ISSN: 1413-3555            Impact factor:   3.377


  36 in total

1.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Authors:  Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

2.  Relationship between daily living activities (ADL) limitation and the BODE index in patients with chronic obstructive pulmonary disease.

Authors:  Karen M Simon; Marta F Carpes; Krislainy S Corrêa; Karoliny dos Santos; Manuela Karloh; Anamaria F Mayer
Journal:  Rev Bras Fisioter       Date:  2011 May-Jun

3.  Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL).

Authors:  R Garrod; J C Bestall; E A Paul; J A Wedzicha; P W Jones
Journal:  Respir Med       Date:  2000-06       Impact factor: 3.415

Review 4.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Thierry Troosters; Milo A Puhan; Véronique Pepin; Didier Saey; Meredith C McCormack; Brian W Carlin; Frank C Sciurba; Fabio Pitta; Jack Wanger; Neil MacIntyre; David A Kaminsky; Bruce H Culver; Susan M Revill; Nidia A Hernandes; Vasileios Andrianopoulos; Carlos Augusto Camillo; Katy E Mitchell; Annemarie L Lee; Catherine J Hill; Sally J Singh
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

Review 5.  Challenges associated with estimating minimal clinically important differences in COPD-the NHLBI perspective.

Authors:  James P Kiley; J Sri Ram; Thomas L Croxton; Gail G Weinmann
Journal:  COPD       Date:  2005-03       Impact factor: 2.409

6.  Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.

Authors:  Ciro Casanova; Jose M Marin; Cristina Martinez-Gonzalez; Pilar de Lucas-Ramos; Isabel Mir-Viladrich; Borja Cosio; German Peces-Barba; Ingrid Solanes-García; Ramón Agüero; Nuria Feu-Collado; Miryam Calle-Rubio; Inmaculada Alfageme; Alfredo de Diego-Damia; Rosa Irigaray; Margarita Marín; Eva Balcells; Antonia Llunell; Juan Bautista Galdiz; Rafael Golpe; Celia Lacarcel; Carlos Cabrera; Alicia Marin; Joan B Soriano; Jose Luis Lopez-Campos; Juan José Soler-Cataluña; Juan P de-Torres
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

Review 7.  Functional status measurement in COPD: a review of available methods and their feasibility in primary care.

Authors:  Janwillem W H Kocks; Guus M Asijee; Ioanna G Tsiligianni; Huib A M Kerstjens; Thys van der Molen
Journal:  Prim Care Respir J       Date:  2011-09

8.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

9.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Authors:  Samantha S C Kon; Jane L Canavan; Sarah E Jones; Claire M Nolan; Amy L Clark; Mandy J Dickson; Brigitte M Haselden; Michael I Polkey; William D-C Man
Journal:  Lancet Respir Med       Date:  2014-02-04       Impact factor: 30.700

10.  The Brazilian Portuguese version of the London Chest Activity of Daily Living scale for use in patients with chronic obstructive pulmonary disease.

Authors:  Marta Fioravante Carpes; Anamaria Fleig Mayer; Karen Muriel Simon; José Roberto Jardim; Rachel Garrod
Journal:  J Bras Pneumol       Date:  2008-03       Impact factor: 2.624

View more
  4 in total

1.  Clinical efficacy of glucocorticoid and terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Yan Li; Zhi Xu; Cuo Qing; Hong Zhang; Xia Wu; Jilu Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 2.  Systematic Review of Physical Activity, Sedentary Behaviour and Sleep Among Adults Living with Chronic Respiratory Disease in Low- and Middle-Income Countries.

Authors:  Akila R Jayamaha; Amy V Jones; Winceslaus Katagira; Bhushan Girase; Zainab K Yusuf; Ilaria Pina; Laura J Wilde; Azamat Akylbekov; Pip Divall; Sally J Singh; Mark W Orme
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-18

Review 3.  Quantifying the Effect of Monitor Wear Time and Monitor Type on the Estimate of Sedentary Time in People with COPD: Systematic Review and Meta-Analysis.

Authors:  Fiona Coll; Vinicius Cavalheri; Daniel F Gucciardi; Sheldon Wulff; Kylie Hill
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

Review 4.  Development Technologies for the Monitoring of Six-Minute Walk Test: A Systematic Review.

Authors:  Ivan Miguel Pires; Hanna Vitaliyivna Denysyuk; María Vanessa Villasana; Juliana Sá; Diogo Luís Marques; José Francisco Morgado; Carlos Albuquerque; Eftim Zdravevski
Journal:  Sensors (Basel)       Date:  2022-01-12       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.